William Eugene Hellenbrand MD

Professor of Pediatrics (Cardiology); Section Chief

Research Interests

Transcatheter treatment of congenital heart disease; Percutaneous pulmonary valve implantation; Covered stents for coarctation of the aorta; ASD closure; PDA closure


Selected Publications

  • Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Gillespie MJ, Rome JJ, Levi DS, Williams RJ, Rhodes JF, Cheatham JP, Hellenbrand WE, Jones TK, Vincent JA, Zahn EM, McElhinney DB. Circ Cardiovasc Interv. 2012 Dec;5(6):862-70 .
  • Reliability and accuracy of echocardiographic right heart evaluation in the U.S. Melody Valve Investigational Trial. Brown DW, McElhinney DB, Araoz PA, Zahn EM, Vincent JA, Cheatham JP, Jones TK, Hellenbrand WE, O'Leary PW. J Am Soc Echocardiogr. 2012 Apr;25(4):383-392.e4. doi: 10.1016/j.echo.2011.12.022. Epub 2012 Jan 21.
  • Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). Bergersen L, Gauvreau K, Foerster SR, Marshall AC, McElhinney DB, Beekman RH 3rd, Hirsch R, Kreutzer J, Balzer D, Vincent J, Hellenbrand WE, Holzer R, Cheatham JP, Moore JW, Burch G, Armsby L, Lock JE, Jenkins KJ. JACC Cardiovasc Interv. 2011 Sep;4(9):1037-46.
  • Short-term performance of the transcatheter Melody valve in high-pressure hemodynamic environments in the pulmonary and systemic circulations. Hasan BS, McElhinney DB, Brown DW, Cheatham JP, Vincent JA, Hellenbrand WE, Jones TK, Zahn EM, Lock JE. Circ Cardiovasc Interv. 2011 Dec 1;4(6):615-20.
  • Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial. McElhinney DB, Cheatham JP, Jones TK, Lock JE, Vincent JA, Zahn EM, Hellenbrand WE. Circ Cardiovasc Interv. 2011 Dec 1;4(6):602-14.
  • Implantation of the Melody Transcatheter Pulmonary Valve in Patients with Dysfunctional Right Ventricular Outflow Tract Conduits: Early Results from the U.S. Clinical Trial. Evan M Zahn, MD, FACC*, William E Hellenbrand, MD, FACC†, James E Lock MD, FACC‡, Doff B McElhinney, MD, FACC JACC 2009 Oct 27;54(18):1722-9.
  • Adverse event rates in congenital cardiac catheterization – A multi-center experience. Bergersen L, Marshall A, Gauvreau K, Beekman R, Hirsch R, Foerster S, Balzer D, Vincent J, Hellenbrand W, Holzer R, Cheatham J, Moore J, Lock J, Jenkins K. Catheter Cardiovasc Interv. 2009 Sep 24

Edit Profile